PsyBio Therapeutics Ret. on assets
What is the Ret. on assets of PsyBio Therapeutics?
The Ret. on assets of PsyBio Therapeutics Corp. is -98.29%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on TSXV compared to PsyBio Therapeutics
What does PsyBio Therapeutics do?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Companies with ret. on assets similar to PsyBio Therapeutics
- O.A.T has Ret. on assets of -98.81%
- Nutritional Growth Solutions has Ret. on assets of -98.81%
- PAVmed has Ret. on assets of -98.78%
- Forte Biosciences has Ret. on assets of -98.67%
- Assure has Ret. on assets of -98.54%
- Precigen Inc has Ret. on assets of -98.51%
- PsyBio Therapeutics has Ret. on assets of -98.29%
- Kaixin Auto has Ret. on assets of -98.24%
- Calithera Biosciences Inc has Ret. on assets of -98.17%
- Personas Social has Ret. on assets of -98.12%
- Q-Gold Resources has Ret. on assets of -98.07%
- Family Insights has Ret. on assets of -97.90%
- Singular Health Ltd has Ret. on assets of -97.79%